National and Kapodistrian University of Athens
Η επίδραση της καπνιστικής συνήθειας στη διαφοροποίηση της φλεγμονής των αεραγωγών σε ασθενείς με άσθμα και χρόνια αποφρακτική πνευμονοπάθεια: συσχέτιση με τη βρογχική αναστρεψιμότητα και βρογχική υπερευαισθησία
Abstract
dc:descriptionDespite a number of important differences in the pathogenesis, course, and prognosis, asthma and chronic obstructive pulmonary disease (COPD) have many features in common. Furthermore, smoking induces considerable overlap in pathogenesis and clinical features between these conditions. This study aimed primarlily to reveal what inflammatory patterns prevail in clinically established diagnosis groups, including overlap phenotypes of asthma and COPD, and to evaluate the correlation with airway reversibility and hyperreactivity in obstractive diseases. Interleukin 18 (IL-18), a pro-inflammatory cytokine generally considered as Th1 type response, has been shown to have a potential regulatory role in asthma by modifying Th2 responses. It has been shown that IL-18 levels in induced sputum are reduced in asthmatic and healthy smokers. However, in COPD patients, recent data show an overproduction in the lungs and increased serum levels of IL-18 suggesting that IL-18 may be involved in the pathogenesis of COPD. As cigarette smoking amplifies airway inflammation in asthma we aimed also to assess the associations of IL-18 with pulmonary function and airway hyperresponsiveness (AHR) in smoking versus non-smoking asthmatics and measure sputums’ IL-18 levels in COPD patients and assess its cellular localazition. Methods: A total of 110 patients (17 healthy subjects, 16 “healthy” smokers, 46 asthma patients -24 smokers and 22 non-smokers- and 31 COPD patients, 10 COPD patients with reversibility and 21 without) participated in the study. Induced sputum, reversibility test, methacholine and AMP provocation challenge and skin prick testing were performed. Airways inflammation was assessed by differential cell counts and cytokines (IL-8, TNF-a and IL-18) were measured in induced sputum by ELISA. Cellular localization of IL-18 was assessed by immunocytochemistry. Results: COPD patients with reversibility had increased sputum neutrophils, IL-8 and TNF-α levels compared to smoking asthmatics, whereas no difference was found in inflammatory cells and cytokines between COPD subgroups. Sputum neutrophilia was inversely correlated to ΔFEV1 in smoking asthmatic patients (r=-0.563, p=0.036). Reversibilty was not correlated to inflammation in COPD patients. However, the response to AMP challenge was correlated to sputum neutrophils (r=0,844, p=0,001). There was no significant difference in IL-18 levels between healthy and asthmatic smokers and between healthy and asthmatic non smokers. IL-18 levels in sputum were significantly lower in healthy smokers compared to non smokers (p=0.048); similarly, in asthmatic smokers as compared to non smokers (p=0.037). The levels of IL-18 were significantly higher in sputum supernatants of COPD patients compared to other study groups (p<0.05). An inverse correlation was found between IL-18 levels, FEV1 (% pred) (r=-0.495, p=0.043), and PD20Mch in non-smoking asthmatics (r=-0.621, p=0.024). A positive correlation was found in smoking asthmatics between IL-18 levels in sputum and FEV1 (% pred) (r=0.627, p=0.002), FVC (% pred) (r=0.460, p=0.031), and PD20Mch (r=0.809, p=0.005). IL-18 levels were inversely correlated with FEV1 (% predicted) (r=-0.572, p=0.002) and FEV1/FVC ratio in COPD smokers (r=-0.608, p=0.001). No correlation was found between IL-18 levels and AHR in COPD patients. IL-18 production was localized to sputum macrophages. Conclusions: : Although overlaps exist in the disease characteristics of asthma and COPD the combination of lung function testing, sputum induction and AHR, reveals information that facilitate the distinction between these diseases, allowing clinicians to better tailor their therapy. Cigarette smoking reduced IL-18 levels in induced sputum in healthy and asthmatic smokers. IL-18 levels were correlated with airflow limitation and AHR in an inverse way in non smoking asthmatics and positively in smoking asthmatics suggesting a different role of IL-18 in airway inflammation in smoking asthmatics. In patients with bronchitis type COPD, increased levels of IL-18 in induced sputum were associated with airflow limitation, suggesting that IL-18 may be implicated in the pathogenesis of COPD.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dima, Efrossini
- Δήμα, Ευφροσύνη
Subjects
dc:subject × 20- Άσθμα
- Χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
- Κάπνισμα
- Φλεγμονή αεραγωγών
- Βρογχική αναστρεψιμότητα
- Βρογχική υπερευαισθησία
- Ιντερλευκίνη-18
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Smoking
- Airways' inflammation
- Bronchial reversibility
- Lung function
- Airway hyperresponsiveness
- Interleukin-18
- IL - 18
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25385